Dystrophin Deficiency Compromises Force Production of the Extensor Carpi Ulnaris Muscle in the Canine Model of Duchenne Muscular Dystrophy

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Yang, Hsiao T ^a   Shin, Jin Hong ^b,c   Hakim, Chady H ^b   Pan, Xiufang ^b   Terjung, Ronald L ^a   Duan, Dongsheng ^b  

^a UNIVERSITY OF MISSOURI   (United States)

^b University of Missouri   (United States)

^c Yangsan Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

DYSTROPHIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARPI ULNARIS MUSCLE; CONTROLLED STUDY; DISEASE MODEL; DOG; DUCHENNE MUSCULAR DYSTROPHY; ECCENTRIC MUSCLE CONTRACTION; EXTENSOR MUSCLE; HISTOPATHOLOGY; MUSCLE BLOOD FLOW; MUSCLE CELL; MUSCLE CONTRACTILITY; MUSCLE DISEASE; MUSCLE FATIGUE; MUSCLE FORCE; MUSCLE LENGTH; MUSCLE MASS; NONHUMAN; PROTEIN DEFICIENCY; SKELETAL MUSCLE;

ANALYSIS OF VARIANCE; ANIMALS; BIOMECHANICS; BLOOD FLOW VELOCITY; BLOOD PRESSURE; DOGS; DYSTROPHIN; HISTOLOGICAL TECHNIQUES; IMAGE PROCESSING, COMPUTER-ASSISTED; MUSCLE WEAKNESS; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE;

CANIS FAMILIARIS; MURINAE;

EID: 84866039008     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044438     Document Type: Article

References (39)

1. Emery AEH, Muntoni F (2003) Duchenne muscular dystrophy. Oxford; New York: Oxford University Press. x, 270 p.
2. Romitti P, Mathews K, Zamba G, Andrews J, Druschel C, et al. (2009) Prevalence of Duchenne/Becker muscular dystrophy among males aged 5-24 years- four states, 2007. MMWR Morb Mortal Wkly Rep 58: 1119-1122.
3. Dooley J, Gordon KE, Dodds L, MacSween J, (2010) Duchenne muscular dystrophy: a 30-year population-based incidence study. Clin Pediatr (Phila) 49: 177-179.
4. Koenig M, Hoffman EP, Bertelson CJ, Monaco AP, Feener C, et al. (1987) Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 50: 509-517.
5. Hoffman EP, Brown RH Jr, Kunkel LM, (1987) Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51: 919-928.
6. Cooper BJ, Winand NJ, Stedman H, Valentine BA, Hoffman EP, et al. (1988) The homologue of the Duchenne locus is defective in X-linked muscular dystrophy of dogs. Nature 334: 154-156.
7. Sicinski P, Geng Y, Ryder-Cook AS, Barnard EA, Darlison MG, et al. (1989) The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science 244: 1578-1580.
8. Bulfield G, Siller WG, Wight PA, Moore KJ, (1984) X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc Natl Acad Sci U S A 81: 1189-1192.
9. Kornegay JN, Tuler SM, Miller DM, Levesque DC, (1988) Muscular dystrophy in a litter of golden retriever dogs. Muscle Nerve 11: 1056-1064.
10. Wells DJ, Wells KE, (2005) What do animal models have to tell us regarding Duchenne muscular dystrophy? Acta Myol 24: 172-180.
11. Shelton GD, Engvall E, (2005) Canine and feline models of human inherited muscle diseases. Neuromuscul Disord 15: 127-138.
12. Howell JM, Fletcher S, Kakulas BA, O'Hara M, Lochmuller H, et al. (1997) Use of the dog model for Duchenne muscular dystrophy in gene therapy trials. Neuromuscul Disord 7: 325-328.
13. Smith BF, Wrighten R, (2010) Animal models for inherited muscle diseases. In: New York: Springer Science + Business Media Duan D, editor. Muscle gene therapy. LLC: 1-21.
14. Duan D, (2011) Duchenne muscular dystrophy gene therapy: lost in translation? Resarch and Report in Biology 2: 31-42.
15. Childers MK, Grange RW, Kornegay JN (2011) In vivo canine muscle function assay. J Vis Exp: pii 2623.
16. Kornegay JN, Sharp NJ, Bogan DJ, Van Camp SD, Metcalf JR, et al. (1994) Contraction tension and kinetics of the peroneus longus muscle in golden retriever muscular dystrophy. J Neurol Sci 123: 100-107.
17. Hakim CH, Li D, Duan D, (2011) Monitoring murine skeletal muscle function for muscle gene therapy. Methods Mol Biol 709: 75-89.
18. Smith BF, Yue Y, Woods PR, Kornegay JN, Shin JH, et al. (2011) An intronic LINE-1 element insertion in the dystrophin gene aborts dystrophin expression and results in Duchenne-like muscular dystrophy in the corgi breed. Lab Invest 91: 216-231.
19. Fine DM, Shin JH, Yue Y, Volkmann D, Leach SB, et al. (2011) Age-matched comparison reveals early electrocardiography and echocardiography changes in dystrophin-deficient dogs. Neuromuscul Disord 21: 453-461.
20. Yue Y, Li Z, Harper SQ, Davisson RL, Chamberlain JS, et al. (2003) Microdystrophin Gene Therapy of Cardiomyopathy Restores Dystrophin-Glycoprotein Complex and Improves Sarcolemma Integrity in the Mdx Mouse Heart. Circulation 108: 1626-1632.
21. Yue Y, Liu M, Duan D, (2006) C-terminal truncated microdystrophin recruits dystrobrevin and syntrophin to the dystrophin-associated glycoprotein complex and reduces muscular dystrophy in symptomatic utrophin/dystrophin double knock-out mice. Mol Ther 14: 79-87.
22. Sacks RD, Roy RR, (1982) Architecture of the hind limb muscles of cats: functional significance. J Morphol 173: 185-195.
23. Ward SR, Kim CW, Eng CM, Gottschalk LJ, Tomiya A, et al. (2009) Architectural analysis and intraoperative measurements demonstrate the unique design of the multifidus muscle for lumbar spine stability. J Bone Joint Surg Am 91: 176-185.
24. Fukunaga T, Roy RR, Shellock FG, Hodgson JA, Day MK, et al. (1992) Physiological cross-sectional area of human leg muscles based on magnetic resonance imaging. J Orthop Res 10: 928-934.
25. Maxwell LC, Faulkner JA, Hyatt GJ, (1974) Estimation of number of fibers in guinea pig skeletal muscles. J Appl Physiol 37: 259-264.
26. Mendez J, Keys A, (1960) Density and composition of mammalian muscle. Metabolism 9: 184-188.
27. Wang Z, Kuhr CS, Allen JM, Blankinship M, Gregorevic P, et al. (2007) Sustained AAV-mediated Dystrophin Expression in a Canine Model of Duchenne Muscular Dystrophy with a Brief Course of Immunosuppression. Mol Ther 15: 1160-1166.
28. Shin JH, Yue Y, Srivastava A, Smith B, Lai Y, et al. (2012) A simplified immune suppression scheme leads to persistent micro-dystrophin expression in duchenne muscular dystrophy dogs. Hum Gene Ther 23: 202-209.
29. Yokota T, Lu QL, Partridge T, Kobayashi M, Nakamura A, et al. (2009) Efficacy of systemic morpholino exon-skipping in duchenne dystrophy dogs. Ann Neurol 65: 667-676.
30. Proske U, Morgan DL, (2001) Muscle damage from eccentric exercise: mechanism, mechanical signs, adaptation and clinical applications. J Physiol 537: 333-345.
31. Tegeler CJ, Grange RW, Bogan DJ, Markert CD, Case D, et al. (2010) Eccentric contractions induce rapid isometric torque drop in dystrophin-deficient dogs. Muscle Nerve 42: 130-132.
32. Athanasopoulos T, Graham IR, Foster H, Dickson G, (2004) Recombinant adeno-associated viral (rAAV) vectors as therapeutic tools for Duchenne muscular dystrophy (DMD). Gene Ther 11 (Suppl 1):: S109-121.
33. Blankinship MJ, Gregorevic P, Chamberlain JS, (2006) Gene therapy strategies for Duchenne muscular dystrophy utilizing recombinant adeno-associated viral vectors. Mol Ther 13: 241-249.
34. Gregorevic P, Plant DR, Lynch GS, (2004) Administration of insulin-like growth factor-I improves fatigue resistance of skeletal muscles from dystrophic mdx mice. Muscle Nerve 30: 295-304.
35. Harcourt LJ, Schertzer JD, Ryall JG, Lynch GS, (2007) Low dose formoterol administration improves muscle function in dystrophic mdx mice without increasing fatigue. Neuromuscul Disord 17: 47-55.
36. Lai Y, Thomas GD, Yue Y, Yang HT, Li D, et al. (2009) Dystrophins carrying spectrin-like repeats 16 and 17 anchor nNOS to the sarcolemma and enhance exercise performance in a mouse model of muscular dystrophy. J Clin Invest 119: 624-635.
37. Thomas GD, Sander M, Lau KS, Huang PL, Stull JT, et al. (1998) Impaired metabolic modulation of alpha-adrenergic vasoconstriction in dystrophin-deficient skeletal muscle. Proc Natl Acad Sci U S A 95: 15090-15095.
38. Sander M, Chavoshan B, Harris SA, Iannaccone ST, Stull JT, et al. (2000) Functional muscle ischemia in neuronal nitric oxide synthase-deficient skeletal muscle of children with Duchenne muscular dystrophy. Proc Natl Acad Sci U S A 97: 13818-13823.
39. Watchko JF, O'Day TL, Hoffman EP, (2002) Functional characteristics of dystrophic skeletal muscle: insights from animal models. J Appl Physiol 93: 407-417.